Xponance Inc. Raises Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Xponance Inc. lifted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 7.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 122,283 shares of the pharmacy operator’s stock after buying an additional 8,740 shares during the quarter. Xponance Inc.’s holdings in Walgreens Boots Alliance were worth $1,141,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of WBA. Brooklyn Investment Group increased its holdings in Walgreens Boots Alliance by 21.1% in the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock valued at $44,000 after buying an additional 830 shares in the last quarter. First Financial Corp IN increased its stake in Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 885 shares in the last quarter. CWA Asset Management Group LLC raised its holdings in Walgreens Boots Alliance by 9.2% during the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock worth $120,000 after purchasing an additional 1,084 shares during the last quarter. Metis Global Partners LLC boosted its position in Walgreens Boots Alliance by 4.9% during the fourth quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator’s stock worth $222,000 after purchasing an additional 1,118 shares in the last quarter. Finally, Harbour Investments Inc. grew its holdings in Walgreens Boots Alliance by 4.3% in the fourth quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator’s stock valued at $265,000 after purchasing an additional 1,165 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 0.2 %

WBA opened at $11.10 on Monday. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.05. The business has a 50-day moving average of $10.96 and a two-hundred day moving average of $9.83. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The stock has a market capitalization of $9.59 billion, a price-to-earnings ratio of -1.08, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance’s revenue was up 7.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.66 earnings per share. On average, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Analysts Set New Price Targets

WBA has been the topic of several recent research reports. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Bank of America upped their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and dropped their price objective for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Evercore ISI upped their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research note on Monday, January 13th. Finally, StockNews.com initiated coverage on Walgreens Boots Alliance in a research report on Tuesday, March 18th. They set a “hold” rating for the company. Four analysts have rated the stock with a sell rating, eight have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.